After CRISPR Therapeutics AG (NASDAQ: CRSP) Surges -10.17% From Highs, What Will It Look Like?
During the last session, CRISPR Therapeutics AG (NASDAQ:CRSP)’s traded shares were 4.58 million, with the beta value of the company hitting 1.79. At the end